Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.1021/acs.molpharmaceut.3c01186

Título: Folic Acid-Decorated Nanocrystals as Highly Loaded Trojan Horses to Target Cancer Cells
Fecha de publicación: jun-2024
Editorial: ACS Publications
Cita bibliográfica: Molecular Pharmaceutics 2024, 21, 6, 2781–2794
ISSN: Print.: 1543-8384
Electronic.: 1543-8392
Palabras clave: Nanocrystals
Surface decoration
EDC/NHS chemistry
Nanosuspensions
Media milling
Resumen: The nanocrystal (NC) technology has become one of the most commonly used strategies for the formulation of poorly soluble actives. Given their large specific surface, NCs are mainly used to enhance the oral absorption of poorly soluble actives. Differently from conventional nanoparticles, which require the use of carrier materials and have limited drug loadings, NCs' drug loading approaches 100% since they are formed of the pure drug and surrounded by a thin layer of a stabilizer. In this work, we report the covalent decoration of curcumin NCs with folic acid (FA) using EDC/NHS chemistry and explore the novel systems as highly loaded "Trojan horses" to target cancer cells. The decorated NCs demonstrated a remarkable improvement in curcumin uptake, exhibiting enhanced growth inhibition in cancer cells (HeLa and MCF7) while sparing healthy cells (J774A.1). Cellular uptake studies revealed significantly heightened entry of FA-decorated NCs into cancer cells compared to unmodified NCs while also showing reduced uptake by macrophages, indicating a potential for prolonged circulation in vivo. These findings underline the potential of NC highly loaded nanovectors for drug delivery and, in particular, for cancer therapies, effectively targeting folate receptor-overexpressing cells while evading interception by macrophages, thus preserving their viability and offering a promising avenue for precise and effective treatments.
Autor/es principal/es: Fuster, M.G.
Wang, J.
Fandiño, O.
Víllora, G.
Paredes, A. J.
URI: http://hdl.handle.net/10201/149829
DOI: https://doi.org/10.1021/acs.molpharmaceut.3c01186
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 14
Derechos: info:eu-repo/semantics/openAccess
Descripción: © 2024 ACS Publications. This document is the published version of a published work that appeared in final form in Molecular Pharmaceutics This document is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0 To access the final edited and published work see: https://doi.org/10.1021/acs.molpharmaceut.3c01186
Aparece en las colecciones:Artículos



Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.